nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitric Oxide—CYP2B6—malignant glioma	0.662	1	CbGaD
Nitric Oxide—CYP1A2—Carmustine—malignant glioma	0.136	0.57	CbGbCtD
Nitric Oxide—CYP3A4—Temozolomide—malignant glioma	0.103	0.43	CbGbCtD
Nitric Oxide—GUCY1A3—retina—malignant glioma	0.00203	0.0552	CbGeAlD
Nitric Oxide—GUCY1B3—retina—malignant glioma	0.00201	0.0548	CbGeAlD
Nitric Oxide—GUCY1A3—telencephalon—malignant glioma	0.00187	0.0508	CbGeAlD
Nitric Oxide—GUCY1B3—telencephalon—malignant glioma	0.00185	0.0504	CbGeAlD
Nitric Oxide—ALDH2—retina—malignant glioma	0.00171	0.0465	CbGeAlD
Nitric Oxide—GUCY1A2—central nervous system—malignant glioma	0.00168	0.0458	CbGeAlD
Nitric Oxide—GUCY1A2—cerebellum—malignant glioma	0.00165	0.0448	CbGeAlD
Nitric Oxide—ALDH2—telencephalon—malignant glioma	0.00157	0.0428	CbGeAlD
Nitric Oxide—GUCY1A3—medulla oblongata—malignant glioma	0.00147	0.0399	CbGeAlD
Nitric Oxide—GUCY1B3—medulla oblongata—malignant glioma	0.00146	0.0396	CbGeAlD
Nitric Oxide—GUCY1A3—midbrain—malignant glioma	0.00134	0.0365	CbGeAlD
Nitric Oxide—GUCY1A2—brain—malignant glioma	0.00134	0.0364	CbGeAlD
Nitric Oxide—GUCY1B3—midbrain—malignant glioma	0.00133	0.0362	CbGeAlD
Nitric Oxide—GUCY1A3—spinal cord—malignant glioma	0.00131	0.0356	CbGeAlD
Nitric Oxide—GUCY1B3—spinal cord—malignant glioma	0.0013	0.0353	CbGeAlD
Nitric Oxide—ALDH2—medulla oblongata—malignant glioma	0.00124	0.0336	CbGeAlD
Nitric Oxide—ALDH2—midbrain—malignant glioma	0.00113	0.0308	CbGeAlD
Nitric Oxide—ALDH2—spinal cord—malignant glioma	0.0011	0.03	CbGeAlD
Nitric Oxide—GUCY1A3—central nervous system—malignant glioma	0.00106	0.0289	CbGeAlD
Nitric Oxide—GUCY1B3—central nervous system—malignant glioma	0.00105	0.0287	CbGeAlD
Nitric Oxide—GUCY1A3—cerebellum—malignant glioma	0.00104	0.0282	CbGeAlD
Nitric Oxide—GUCY1B3—cerebellum—malignant glioma	0.00103	0.028	CbGeAlD
Nitric Oxide—ALDH2—central nervous system—malignant glioma	0.000894	0.0243	CbGeAlD
Nitric Oxide—ALDH2—cerebellum—malignant glioma	0.000874	0.0238	CbGeAlD
Nitric Oxide—GUCY1A3—brain—malignant glioma	0.000842	0.0229	CbGeAlD
Nitric Oxide—GUCY1B3—brain—malignant glioma	0.000836	0.0228	CbGeAlD
Nitric Oxide—ALDH2—brain—malignant glioma	0.00071	0.0193	CbGeAlD
Nitric Oxide—Cerebral infarction—Carmustine—malignant glioma	0.000707	0.228	CcSEcCtD
Nitric Oxide—Haemorrhage intracranial—Temozolomide—malignant glioma	0.000542	0.175	CcSEcCtD
Nitric Oxide—CYP2B6—central nervous system—malignant glioma	0.000401	0.0109	CbGeAlD
Nitric Oxide—CYP2B6—brain—malignant glioma	0.000319	0.00867	CbGeAlD
Nitric Oxide—CYP3A4—central nervous system—malignant glioma	0.000303	0.00825	CbGeAlD
Nitric Oxide—ALDH2—Neuronal System—BCHE—malignant glioma	0.000242	0.00401	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL1B—malignant glioma	0.00023	0.00382	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—KNG1—malignant glioma	0.00023	0.0038	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—KNG1—malignant glioma	0.00023	0.0038	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—SLC6A3—malignant glioma	0.000227	0.00377	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000227	0.00376	CbGpPWpGaD
Nitric Oxide—CYP1A2—Tryptophan metabolism—CYP2C18—malignant glioma	0.000227	0.00376	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IFNA2—malignant glioma	0.000225	0.00372	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—IFNA2—malignant glioma	0.000225	0.00372	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—SOD1—malignant glioma	0.000213	0.00353	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—SOD1—malignant glioma	0.000213	0.00353	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000212	0.00351	CbGpPWpGaD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000209	0.00346	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—KNG1—malignant glioma	0.000205	0.00339	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IFNA2—malignant glioma	0.000201	0.00332	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PTK2—malignant glioma	0.000196	0.00324	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PTK2—malignant glioma	0.000196	0.00324	CbGpPWpGaD
Nitric Oxide—CYP2B6—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000192	0.00317	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—SOD1—malignant glioma	0.00019	0.00315	CbGpPWpGaD
Nitric Oxide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000184	0.00304	CbGpPWpGaD
Nitric Oxide—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000181	0.003	CbGpPWpGaD
Nitric Oxide—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000181	0.003	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000175	0.0029	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PTK2—malignant glioma	0.000175	0.00289	CbGpPWpGaD
Nitric Oxide—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000174	0.00287	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000172	0.00284	CbGpPWpGaD
Nitric Oxide—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000167	0.0539	CcSEcCtD
Nitric Oxide—ALDH2—Metabolism—COX8A—malignant glioma	0.000165	0.00273	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PDGFB—malignant glioma	0.000165	0.00272	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PDGFB—malignant glioma	0.000165	0.00272	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000163	0.00271	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000161	0.00267	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—BRAF—malignant glioma	0.000161	0.00267	CbGpPWpGaD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—PTGS1—malignant glioma	0.000161	0.00266	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	0.00016	0.00265	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—CAV1—malignant glioma	0.000156	0.00258	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—CAV1—malignant glioma	0.000156	0.00258	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000149	0.00246	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—FN1—malignant glioma	0.000148	0.00246	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—FN1—malignant glioma	0.000148	0.00246	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—F2—malignant glioma	0.000148	0.00246	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—F2—malignant glioma	0.000148	0.00246	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PDGFB—malignant glioma	0.000147	0.00243	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PIK3CG—malignant glioma	0.000142	0.00235	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PIK3CG—malignant glioma	0.000142	0.00235	CbGpPWpGaD
Nitric Oxide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000142	0.00235	CbGpPWpGaD
Nitric Oxide—CYP1A2—Estrogen Receptor Pathway—STAT3—malignant glioma	0.000141	0.00234	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—EGF—malignant glioma	0.00014	0.00232	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—EGF—malignant glioma	0.00014	0.00232	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—ASMT—malignant glioma	0.00014	0.00232	CbGpPWpGaD
Nitric Oxide—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.00014	0.00231	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PTPN11—malignant glioma	0.00014	0.00231	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PTPN11—malignant glioma	0.00014	0.00231	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—CAV1—malignant glioma	0.000139	0.0023	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—MDM2—malignant glioma	0.000135	0.00224	CbGpPWpGaD
Nitric Oxide—ALDH2—Transmission across Chemical Synapses—RAF1—malignant glioma	0.000135	0.00223	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—CYP2C18—malignant glioma	0.000134	0.00222	CbGpPWpGaD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000132	0.00219	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—CYP2C18—malignant glioma	0.000132	0.00219	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—FN1—malignant glioma	0.000132	0.00219	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—F2—malignant glioma	0.000132	0.00219	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—BCAN—malignant glioma	0.000132	0.00218	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—AKT2—malignant glioma	0.00013	0.00215	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—AKT2—malignant glioma	0.00013	0.00215	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PIK3CG—malignant glioma	0.000127	0.0021	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—EGF—malignant glioma	0.000125	0.00207	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PIK3CD—malignant glioma	0.000125	0.00207	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PIK3CD—malignant glioma	0.000125	0.00207	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PTPN11—malignant glioma	0.000124	0.00206	CbGpPWpGaD
Nitric Oxide—CYP1A2—Tryptophan metabolism—CAT—malignant glioma	0.000124	0.00205	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—BRAF—malignant glioma	0.000123	0.00204	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	0.000118	0.00195	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Carmustine—malignant glioma	0.000116	0.0375	CcSEcCtD
Nitric Oxide—GUCY1A3—Hemostasis—AKT2—malignant glioma	0.000116	0.00192	CbGpPWpGaD
Nitric Oxide—Haemorrhage—Carmustine—malignant glioma	0.000116	0.0373	CcSEcCtD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000115	0.0019	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000113	0.00187	CbGpPWpGaD
Nitric Oxide—Haemoglobin—Temozolomide—malignant glioma	0.000112	0.0362	CcSEcCtD
Nitric Oxide—Haemorrhage—Temozolomide—malignant glioma	0.000112	0.0361	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—RAF1—malignant glioma	0.000111	0.00185	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—RAF1—malignant glioma	0.000111	0.00185	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PIK3CD—malignant glioma	0.000111	0.00184	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	0.000109	0.00181	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PIK3CB—malignant glioma	0.000109	0.0018	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PIK3CB—malignant glioma	0.000109	0.0018	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTT1—malignant glioma	0.000109	0.0018	CbGpPWpGaD
Nitric Oxide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000107	0.00177	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—IDH2—malignant glioma	0.000106	0.00176	CbGpPWpGaD
Nitric Oxide—Cardiac disorder—Temozolomide—malignant glioma	0.000104	0.0335	CcSEcCtD
Nitric Oxide—ALDH2—Neuronal System—MDM2—malignant glioma	0.000103	0.00171	CbGpPWpGaD
Nitric Oxide—ALDH2—Neuronal System—RAF1—malignant glioma	0.000103	0.00171	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—PTGS1—malignant glioma	0.000102	0.00168	CbGpPWpGaD
Nitric Oxide—Angiopathy—Temozolomide—malignant glioma	0.000101	0.0327	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Temozolomide—malignant glioma	0.000101	0.0325	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—IL2—malignant glioma	0.0001	0.00165	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—IL2—malignant glioma	0.0001	0.00165	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP2B6—malignant glioma	9.97e-05	0.00165	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—RAF1—malignant glioma	9.94e-05	0.00165	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PIK3CB—malignant glioma	9.7e-05	0.00161	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	9.56e-05	0.00158	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—IDH1—malignant glioma	9.12e-05	0.00151	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	9.12e-05	0.00151	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	8.99e-05	0.00149	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—IL2—malignant glioma	8.91e-05	0.00148	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—SPHK1—malignant glioma	8.83e-05	0.00146	CbGpPWpGaD
Nitric Oxide—Convulsion—Carmustine—malignant glioma	8.72e-05	0.0281	CcSEcCtD
Nitric Oxide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	8.7e-05	0.00144	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CYP2C18—malignant glioma	8.65e-05	0.00143	CbGpPWpGaD
Nitric Oxide—Chest pain—Carmustine—malignant glioma	8.57e-05	0.0276	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—VEGFA—malignant glioma	8.49e-05	0.00141	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—VEGFA—malignant glioma	8.49e-05	0.00141	CbGpPWpGaD
Nitric Oxide—Convulsion—Temozolomide—malignant glioma	8.43e-05	0.0272	CcSEcCtD
Nitric Oxide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	8.24e-05	0.00136	CbGpPWpGaD
Nitric Oxide—Thrombocytopenia—Carmustine—malignant glioma	8.04e-05	0.0259	CcSEcCtD
Nitric Oxide—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	7.9e-05	0.00131	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	7.8e-05	0.00129	CbGpPWpGaD
Nitric Oxide—Nervous system disorder—Temozolomide—malignant glioma	7.79e-05	0.0251	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Temozolomide—malignant glioma	7.77e-05	0.0251	CcSEcCtD
Nitric Oxide—Hypotension—Carmustine—malignant glioma	7.68e-05	0.0248	CcSEcCtD
Nitric Oxide—CYP2B6—Metabolism—RTEL1—malignant glioma	7.61e-05	0.00126	CbGpPWpGaD
Nitric Oxide—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	7.57e-05	0.00125	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—VEGFA—malignant glioma	7.57e-05	0.00125	CbGpPWpGaD
Nitric Oxide—CYP2B6—Biological oxidations—GSTP1—malignant glioma	7.53e-05	0.00125	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metapathway biotransformation—GSTP1—malignant glioma	7.42e-05	0.00123	CbGpPWpGaD
Nitric Oxide—Dyspnoea—Carmustine—malignant glioma	7.32e-05	0.0236	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—KRAS—malignant glioma	7.22e-05	0.0012	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—KRAS—malignant glioma	7.22e-05	0.0012	CbGpPWpGaD
Nitric Oxide—Dyspnoea—Temozolomide—malignant glioma	7.08e-05	0.0228	CcSEcCtD
Nitric Oxide—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	7.04e-05	0.00116	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTT1—malignant glioma	6.99e-05	0.00116	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	6.94e-05	0.00115	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	6.88e-05	0.00114	CbGpPWpGaD
Nitric Oxide—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	6.84e-05	0.00113	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	6.82e-05	0.00113	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—PIK3CA—malignant glioma	6.63e-05	0.0011	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—PIK3CA—malignant glioma	6.63e-05	0.0011	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	6.59e-05	0.00109	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PTGS1—malignant glioma	6.55e-05	0.00109	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—KRAS—malignant glioma	6.44e-05	0.00107	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—TP53—malignant glioma	6.42e-05	0.00106	CbGpPWpGaD
Nitric Oxide—GUCY1A2—Hemostasis—TP53—malignant glioma	6.42e-05	0.00106	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTT1—malignant glioma	6.39e-05	0.00106	CbGpPWpGaD
Nitric Oxide—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	6.17e-05	0.00102	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	6.13e-05	0.00102	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	6.11e-05	0.00101	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	6.1e-05	0.00101	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—BCHE—malignant glioma	6.09e-05	0.00101	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—SLC5A5—malignant glioma	6.02e-05	0.000996	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	6.02e-05	0.000996	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—PTGS1—malignant glioma	5.99e-05	0.000992	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—PIK3CA—malignant glioma	5.91e-05	0.000979	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—TP53—malignant glioma	5.72e-05	0.000947	CbGpPWpGaD
Nitric Oxide—Dizziness—Carmustine—malignant glioma	5.43e-05	0.0175	CcSEcCtD
Nitric Oxide—GUCY1A2—Hemostasis—AKT1—malignant glioma	5.42e-05	0.000897	CbGpPWpGaD
Nitric Oxide—GUCY1B3—Hemostasis—AKT1—malignant glioma	5.42e-05	0.000897	CbGpPWpGaD
Nitric Oxide—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	5.28e-05	0.000874	CbGpPWpGaD
Nitric Oxide—Dizziness—Temozolomide—malignant glioma	5.25e-05	0.0169	CcSEcCtD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	5.19e-05	0.00086	CbGpPWpGaD
Nitric Oxide—Headache—Carmustine—malignant glioma	5.15e-05	0.0166	CcSEcCtD
Nitric Oxide—Headache—Temozolomide—malignant glioma	4.97e-05	0.016	CcSEcCtD
Nitric Oxide—CYP3A4—Biological oxidations—GSTT1—malignant glioma	4.93e-05	0.000817	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—GSTP1—malignant glioma	4.85e-05	0.000803	CbGpPWpGaD
Nitric Oxide—GUCY1A3—Hemostasis—AKT1—malignant glioma	4.83e-05	0.0008	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	4.78e-05	0.000791	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CAT—malignant glioma	4.72e-05	0.000781	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	4.67e-05	0.000774	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	4.67e-05	0.000774	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—PTGS1—malignant glioma	4.62e-05	0.000765	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—RTEL1—malignant glioma	4.48e-05	0.000742	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—NCOR1—malignant glioma	4.45e-05	0.000738	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	4.45e-05	0.000737	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	4.45e-05	0.000737	CbGpPWpGaD
Nitric Oxide—CYP1A2—Biological oxidations—GSTP1—malignant glioma	4.43e-05	0.000734	CbGpPWpGaD
Nitric Oxide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	4.42e-05	0.000731	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—COX8A—malignant glioma	4.37e-05	0.000724	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	4.37e-05	0.000724	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ASMT—malignant glioma	3.72e-05	0.000615	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—CAV1—malignant glioma	3.63e-05	0.000601	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—BCAN—malignant glioma	3.49e-05	0.000578	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—RTEL1—malignant glioma	3.46e-05	0.000572	CbGpPWpGaD
Nitric Oxide—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.42e-05	0.000566	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	3.37e-05	0.000558	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PIK3CG—malignant glioma	3.31e-05	0.000548	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.2e-05	0.00053	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PPARG—malignant glioma	3.19e-05	0.000529	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.1e-05	0.000513	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PIK3CD—malignant glioma	2.91e-05	0.000481	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—IDH2—malignant glioma	2.82e-05	0.000466	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—COX8A—malignant glioma	2.57e-05	0.000426	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PIK3CB—malignant glioma	2.53e-05	0.00042	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PTGS2—malignant glioma	2.51e-05	0.000416	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—IDH1—malignant glioma	2.42e-05	0.000401	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SPHK1—malignant glioma	2.34e-05	0.000388	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.3e-05	0.000381	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP2C18—malignant glioma	2.3e-05	0.00038	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PTEN—malignant glioma	2.19e-05	0.000363	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ASMT—malignant glioma	2.19e-05	0.000362	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.14e-05	0.000354	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—BCAN—malignant glioma	2.06e-05	0.000341	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—COX8A—malignant glioma	1.99e-05	0.000329	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTT1—malignant glioma	1.86e-05	0.000307	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTGS1—malignant glioma	1.74e-05	0.000288	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ASMT—malignant glioma	1.69e-05	0.00028	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—IDH2—malignant glioma	1.66e-05	0.000275	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—BCHE—malignant glioma	1.62e-05	0.000268	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SLC5A5—malignant glioma	1.6e-05	0.000265	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—BCAN—malignant glioma	1.59e-05	0.000263	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.56e-05	0.000259	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP2B6—malignant glioma	1.56e-05	0.000258	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PIK3CA—malignant glioma	1.54e-05	0.000256	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—IDH1—malignant glioma	1.43e-05	0.000236	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SPHK1—malignant glioma	1.38e-05	0.000228	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP2C18—malignant glioma	1.35e-05	0.000224	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTP1—malignant glioma	1.29e-05	0.000213	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—IDH2—malignant glioma	1.28e-05	0.000212	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.27e-05	0.000211	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—AKT1—malignant glioma	1.26e-05	0.000209	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CAT—malignant glioma	1.25e-05	0.000207	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.2e-05	0.000199	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NCOR1—malignant glioma	1.18e-05	0.000196	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.16e-05	0.000192	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.12e-05	0.000186	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—IDH1—malignant glioma	1.1e-05	0.000182	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTT1—malignant glioma	1.09e-05	0.000181	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SPHK1—malignant glioma	1.06e-05	0.000176	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.04e-05	0.000173	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTGS1—malignant glioma	1.02e-05	0.00017	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.02e-05	0.000169	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CAV1—malignant glioma	9.64e-06	0.00016	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—BCHE—malignant glioma	9.52e-06	0.000158	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SLC5A5—malignant glioma	9.41e-06	0.000156	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	8.9e-06	0.000147	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	8.81e-06	0.000146	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CG—malignant glioma	8.78e-06	0.000145	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PPARG—malignant glioma	8.48e-06	0.00014	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTT1—malignant glioma	8.44e-06	0.00014	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTGS1—malignant glioma	7.91e-06	0.000131	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CD—malignant glioma	7.72e-06	0.000128	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	7.69e-06	0.000127	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTP1—malignant glioma	7.58e-06	0.000125	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CAT—malignant glioma	7.37e-06	0.000122	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—BCHE—malignant glioma	7.35e-06	0.000122	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.26e-06	0.00012	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NCOR1—malignant glioma	6.96e-06	0.000115	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CB—malignant glioma	6.73e-06	0.000111	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTGS2—malignant glioma	6.67e-06	0.00011	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTP1—malignant glioma	5.85e-06	9.68e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTEN—malignant glioma	5.81e-06	9.63e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CAT—malignant glioma	5.69e-06	9.42e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CAV1—malignant glioma	5.68e-06	9.4e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	5.42e-06	8.98e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NCOR1—malignant glioma	5.37e-06	8.9e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CG—malignant glioma	5.17e-06	8.56e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PPARG—malignant glioma	4.99e-06	8.26e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CD—malignant glioma	4.55e-06	7.53e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CAV1—malignant glioma	4.38e-06	7.25e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CA—malignant glioma	4.1e-06	6.79e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.99e-06	6.61e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CB—malignant glioma	3.96e-06	6.56e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTGS2—malignant glioma	3.93e-06	6.5e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PPARG—malignant glioma	3.85e-06	6.38e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.51e-06	5.81e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTEN—malignant glioma	3.42e-06	5.67e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—AKT1—malignant glioma	3.35e-06	5.55e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.06e-06	5.06e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTGS2—malignant glioma	3.03e-06	5.02e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTEN—malignant glioma	2.64e-06	4.37e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CA—malignant glioma	2.42e-06	4e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—AKT1—malignant glioma	1.97e-06	3.27e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.86e-06	3.09e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—AKT1—malignant glioma	1.52e-06	2.52e-05	CbGpPWpGaD
